Shanghai Xuerong Bio-Technology Co Ltd (300511) — Capital Reinvestment Ratio
Shanghai Xuerong Bio-Technology Co Ltd (300511) has a Capital Reinvestment Ratio of 0.31x as of September 2022, meaning it reinvests 0% of its operating cash flow (CN¥190.71 Million) in capital expenditures (CN¥58.20 Million). See how leveraged is Shanghai Xuerong Bio-Technology Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Xuerong Bio-Technology Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Shanghai Xuerong Bio-Technology Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check Shanghai Xuerong Bio-Technology Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see market cap of Shanghai Xuerong Bio-Technology Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.75x | CN¥437.20 Million | CN¥327.46 Million | ▼ -75.6% |
| 2023 | 3.07x | CN¥357.84 Million | CN¥1.10 Billion | ▲ +252.3% |
| 2022 | 0.87x | CN¥367.13 Million | CN¥319.47 Million | ▼ -66.4% |
| 2021 | 2.59x | CN¥246.75 Million | CN¥639.87 Million | ▲ +198.4% |
| 2020 | 0.87x | CN¥555.47 Million | CN¥482.79 Million | ▲ +63.3% |
| 2019 | 0.53x | CN¥586.93 Million | CN¥312.38 Million | ▼ -51.0% |
| 2018 | 1.09x | CN¥406.82 Million | CN¥442.23 Million | ▼ -69.7% |
| 2017 | 3.59x | CN¥328.64 Million | CN¥1.18 Billion | ▲ +63.9% |
| 2016 | 2.19x | CN¥317.71 Million | CN¥695.20 Million | ▲ +111.1% |
| 2015 | 1.04x | CN¥273.77 Million | CN¥283.78 Million | ▲ +61.0% |
| 2014 | 0.64x | CN¥253.24 Million | CN¥163.01 Million | ▼ -23.7% |
| 2013 | 0.84x | CN¥235.07 Million | CN¥198.39 Million | ▼ -83.1% |
| 2012 | 4.99x | CN¥112.14 Million | CN¥559.93 Million | — |